【ChiCTR2000030403】Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study
ChiCTR2000030403
正在进行
/
/
/
2020-03-01
/
/
肝细胞癌
Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study
Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study
to evaluate the prognostic value of total tumor volume (TTV) in resection of hepatocellular carcinoma (HCC).
队列研究
回顾性研究
N/A
N/A
No funding
/
204
/
2012-01-01
2017-01-01
/
Patients enrolled in the study had HCC on top of cirrhotic liver, Child-Turcotte-Pugh (CTP) score A5 or A6, and underwent R0 curative liver resection.；
请登录查看HCC in non cirrhotic liver, Child Bor C, other tumors than HCC；
请登录查看埃及梅努菲亚大学国家肝病研究所
/
埃及梅努菲亚大学国家肝病研究所的其他临床试验
- Prognostic factors for long-term survival after pancreaticoduodenectomy for periampullary adenocarcinoma
- Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study
- Surgical (Open and laparoscopic) management of large difficult CBD ston
埃及梅努菲亚大学国家肝病研究所的其他临床试验
- Short- and long-term outcomes after Kasai operation for type III biliary atresia: Twenty years of experience in a single tertiary Egyptian centre.
- Prognostic factors for long-term survival after pancreaticoduodenectomy for periampullary adenocarcinoma
- The Impact of Clinicopathological factors on long-term patient survival Post Whipple's operation for periampullary carcinoma
- Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study
- Surgical (Open and laparoscopic) management of large difficult CBD ston
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04